PM8001 / Biotheus  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PM8001 / Biotheus
ChiCTR2100052617: Phase I study for PM8001 plus chemotherapy or targeted drugs in the treatment of patients with lung cancer

Recruiting
1
92
 
PM8001 plus chemotherapy ;PM8001 plus targeted drugs
Shanghai Chest Hospital; Shanghai Chest Hospital, Pumis Biotechnology (Zhuhai) Co., Ltd.
lung cancer
 
 
ChiCTR2000033828: Phase I/IIa study for PM8001 in the treatment of patients with advanced solid tumors

Not yet recruiting
1
247
 
PM8001 injection ;PM8001 injection
Shanghai Orient Hospital; Shanghai East Hospital, Biotheus Inc.
advanced solid tumors
 
 
NCT05537051: A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours

Not yet recruiting
1
30
NA
PM1021, PM8001
Biotheus Inc.
Advanced Solid Tumours
10/24
12/25

Download Options